Cargando…
Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
PURPOSE: To describe the effect of tocilizumab in two patients with thyroid associated orbitopathy (TAO). OBSERVATIONS: We present two patients with TAO who could not tolerate corticosteroids and had a reduction in clinical and laboratory markers of inflammatory activity with subsequent tocilizumab...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722155/ https://www.ncbi.nlm.nih.gov/pubmed/29260102 http://dx.doi.org/10.1016/j.ajoc.2017.07.001 |